Skip to content
News And Views

Thor Equities Group Executes First Lease at 95 Greene Street, the First Lab-Ready Life Sciences Property in Jersey City, NJ

Thor Equities Group Executes First Lease at 95 Greene Street, the First Lab-Ready Life Sciences Property in Jersey City, NJ

Jersey City, NJ., October 14, 2021 – Thor Equities Group, a global leader in real estate development, leasing, and management, is pleased to announce a long-term lease with RWJ Barnabas Health/JCMC, for 11,000 square feet at 95 Greene Street in Jersey City.

Offering full-spectrum medical care in New Jersey’s Hudson County, RWJ Barnabas Health/JCMC’s new location will operate as a primary and urgent care center. Outfitted with the latest technologies to provide the highest standard of care for patients, the tenant will have their own separate entrance on York Street and benefit from an excellent location in Jersey City’s Paulus Hook neighborhood.

Encompassing 350,000-square-feet over eight levels, 95 Greene Street previously served as a manufacturing facility for Colgate Palmolive until 1987 and was later converted into a Class-A office building occupied by Merrill Lynch. 95G offers robust utilities infrastructure and abundant power resources served by multiple utility grids. The property offers 13- to 15-foot ceiling heights, secured interior loading docks, on-site life-safety generator, and flexible floor plates. Onsite underground parking is available for 125 vehicles. Thor worked with SGA Architects to complete a comprehensive adaptive reuse project for 95 Greene Street. Base building work included extensive upgrades to mechanicals, HVAC, vertical conduits, and a new rooftop generator.

“We are very pleased to welcome RWJ Barnanbas/JCMC to their new home at 95 Greene Street. We are proud of our work at this development and are committed to providing organizations with state-of-the-art spaces to practice medicine and advance life sciences. 95 Greene benefits from powerful building infrastructure and we look forward to welcoming additional tenants to this trophy asset,” said Chairman of Thor Equities Group, Joe Sitt.

Thor’s life science portfolio includes two additional life science facilities in New Jersey; 7 Powder Horn Drive in Warren which is occupied by Celgene BMS, and The New Jersey Center of Excellence in Bridgewater, a 784,000-square-foot secure campus leased to life science companies including anchor tenants Nestlé Health Science, Ashland, Amneal Pharmaceuticals, and PTC Therapeutics. Thor also recently acquired an R&D asset leased to semiconductor developer NXP Semiconductors in San Jose as well as a life science campus in the Research Triangle space of North Carolina within the last year.


Thor Equities is a leader in the development, leasing and management of office, industrial, laboratory, residential, hotel and mixed-use assets in premier urban locations worldwide. The company operates in major cities around the globe and has a property portfolio totaling $20 billion with a development pipeline in excess of 50 million square feet. Thor has a strong presence on three continents and in addition to its US holdings, the company has assets in European gateway cities including London, Paris, Madrid, and Milan, and is the largest developer in Mexico through its Latin American division with a development pipeline of over 18 million square feet. Thor maximizes returns for institutional investors by recognizing a property’s potential, reducing operating expenses, increasing tenant satisfaction, leveraging market trends to maintain a long-term competitive edge. For more information, visit

Previous StoryNext Story
Next/Previous StoryNext Story
Back to Insights